Moreover, the gene expression of TAK1 was markedly higher among primary and secondary APS patients compared with healthy cases to 1.7-fold (P = 0.03) and 6.1-fold (P < 0.001), respectively. The gene discussed is MAP3K7; the disease is autoimmune polyendocrinopathy.